White matter hyperintensities in cholinergic pathways may predict poorer responsiveness to acetylcholinesterase inhibitor treatment for Alzheimer's disease.
- Published in:
- PLoS ONE, 2023, v. 18, n. 3, p. 1, doi. 10.1371/journal.pone.0283790
- By:
- Publication type:
- Article